NCT07772024
- Conditions
- Multiple Myeloma Refractory, Multiple Myeloma in Relapse
- Locations
-
- Regis Clinical Research Miami, Florida, United States
Clinical trial condition
Multiple Myeloma Refractory
Explore clinical trials studying Multiple Myeloma Refractory. Study availability and eligibility vary by location and protocol.
13 public trials
7 recruiting studies
Multiple Myeloma Refractory trial results
NCT07771803
- Conditions
- AML (Acute Myeloid Leukemia), Disease Attributes, Hematologic Diseases, +10 more
- Locations
-
- MDA at Cooper University Health Care Camden, New Jersey, United States
NCT07637578
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
- SCRI Oncology Partners Nashville, Tennessee, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
NCT07096778
- Conditions
- Multiple Myeloma Refractory, Multiple Myeloma in Relapse
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- H Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- Winship Cancer Institute Atlanta, Georgia, United States
- American Oncology Partners, PA Bethesda, Maryland, United States
NCT07094048
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Santé Québec Chaudière-Appalaches Lévis, Quebec, Canada
- Centre Intégré de Cancérologie Québec, Quebec, Canada
NCT07456605
- Conditions
- Multiple Myeloma Refractory, Multiple Myeloma in Relapse
- Locations
-
- University Health Network-Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07477912
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Hematology Minsk, Belarus
Not yet recruiting
BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma
NCT07771361
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +28 more
- Locations
-
Not specified
Not yet recruiting
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
NCT07634263
- Conditions
- Behavior, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark
- Odense University Hospital Odense, Denmark
- Sjællands Universitets Hospital Roskilde, Denmark
Not yet recruiting
Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM)
NCT07622862
- Conditions
- Multiple Myeloma Progression, Multiple Myeloma Refractory
- Locations
-
Not specified